AAAAAA

   
Results: 1-7 |
Results: 7
SELECTION CONDITIONS AFFECT THE EVOLUTION OF SPECIFIC MUTATIONS IN THE REVERSE-TRANSCRIPTASE GENE ASSOCIATED WITH RESISTANCE TO DMP-266
Authors: WINSLOW DL GARBER S REID C SCARNATI H BAKER D RAYNER MM ANTON ED
Citation: Dl. Winslow et al., SELECTION CONDITIONS AFFECT THE EVOLUTION OF SPECIFIC MUTATIONS IN THE REVERSE-TRANSCRIPTASE GENE ASSOCIATED WITH RESISTANCE TO DMP-266, AIDS, 10(11), 1996, pp. 1205-1209
DEVELOPMENT OF HIGH-LEVEL RESISTANCE TO DMP-266 REQUIRES MULTIPLE MUTATIONS IN THE REVERSE-TRANSCRIPTASE GENE
Authors: WINSLOW DL GARBER S REID C SCARNATI H KORANT B EMINI E ANTON ED
Citation: Dl. Winslow et al., DEVELOPMENT OF HIGH-LEVEL RESISTANCE TO DMP-266 REQUIRES MULTIPLE MUTATIONS IN THE REVERSE-TRANSCRIPTASE GENE, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 13-13
REPLICATIVE ABILITY OF HIV VARIANTS WITH SUBSTITUTIONS IN THE ACTIVE-SITE OF PROTEASE IS DEPENDENT ON COMPENSATORY MUTATIONS OUTSIDE THE ACTIVE-SITE
Authors: ANTON ED BACHELER L GARBER S REID C BUCKERY R SCARNATI H KORANT B WINSLOW DL
Citation: Ed. Anton et al., REPLICATIVE ABILITY OF HIV VARIANTS WITH SUBSTITUTIONS IN THE ACTIVE-SITE OF PROTEASE IS DEPENDENT ON COMPENSATORY MUTATIONS OUTSIDE THE ACTIVE-SITE, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 60-60
LIMITED SEQUENCE DIVERSITY OF THE HIV TYPE-1 PROTEASE GENE FROM CLINICAL ISOLATES AND IN-VITRO SUSCEPTIBILITY TO HIV PROTEASE INHIBITORS
Authors: WINSLOW DL STACK S KING R SCARNATI H BINCSIK A OTTO MJ
Citation: Dl. Winslow et al., LIMITED SEQUENCE DIVERSITY OF THE HIV TYPE-1 PROTEASE GENE FROM CLINICAL ISOLATES AND IN-VITRO SUSCEPTIBILITY TO HIV PROTEASE INHIBITORS, AIDS research and human retroviruses, 11(1), 1995, pp. 107-113
IN-VITRO SUSCEPTIBILITY OF CLINICAL ISOLATES OF HIV-1 TO XM323, A NON-PEPTIDYL HIV PROTEASE INHIBITOR
Authors: WINSLOW DL MAYERS D SCARNATI H LANE J BINCSIK A OTTO MJ
Citation: Dl. Winslow et al., IN-VITRO SUSCEPTIBILITY OF CLINICAL ISOLATES OF HIV-1 TO XM323, A NON-PEPTIDYL HIV PROTEASE INHIBITOR, AIDS, 8(6), 1994, pp. 753-756
CONSTRUCTION OF INFECTIOUS MOLECULAR CLONES OF HIV-1 CONTAINING DEFINED MUTATIONS IN THE PROTEASE GENE
Authors: WINSLOW DL ANTON ED HORLICK RA ZAGURSKY RJ TRITCH RJ SCARNATI H ACKERMAN K BACHELER LT
Citation: Dl. Winslow et al., CONSTRUCTION OF INFECTIOUS MOLECULAR CLONES OF HIV-1 CONTAINING DEFINED MUTATIONS IN THE PROTEASE GENE, Biochemical and biophysical research communications, 205(3), 1994, pp. 1651-1657
IN-VITRO ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ACTIVITY OF XM323, ANOVEL HIV PROTEASE INHIBITOR
Authors: OTTO MJ REID CD GARBER S LAM PYS SCARNATI H BACHELER LT RAYNER MM WINSLOW DL
Citation: Mj. Otto et al., IN-VITRO ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ACTIVITY OF XM323, ANOVEL HIV PROTEASE INHIBITOR, Antimicrobial agents and chemotherapy, 37(12), 1993, pp. 2606-2611
Risultati: 1-7 |